Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Carrie L. Frey is active.

Publication


Featured researches published by Carrie L. Frey.


Journal of Immunology | 2000

Identification of Unique Truncated KC/GROβ Chemokines with Potent Hematopoietic and Anti-Infective Activities

Andrew G. King; Kyung Johanson; Carrie L. Frey; Peter DeMarsh; John R. White; Patrick McDevitt; Dean E. McNulty; Joanna Maria Balcarek; Zdenka L. Jonak; Pradip K. Bhatnagar; Louis M. Pelus

SK&F 107647, a previously described synthetic immunomodulatory peptide, indirectly stimulates bone marrow progenitor cells and phagocytic cells, and enhances host defense effector mechanisms in bacterial and fungal infection models in vivo. In vitro, SK&F 107647 induces the production of a soluble mediator that augments colony forming cell (CFU-GM) formation in the presence of CSFs. In this paper we purified and sequenced the stromal cell-derived hematopoietic synergistic factors (HSF) secreted from both murine and human cell lines stimulated with SK&F 107647. Murine HSF is an N-terminal 4-aa truncated form of the CXC chemokine, KC, while human HSF was identified as an N-terminal 4-aa truncated form of the CXC chemokine, GROβ. In comparison to their full-length forms, truncated KC and truncated GROβ were 10 million times more potent as synergistic growth stimulants for CFU-GM. Enhanced potency of these novel truncated chemokines relative to their full-length forms was also demonstrated in respiratory burst assays, CD11b Ag expression, and intracellular killing of the opportunistic pathogen, Candida albicans. Administration of truncated KC significantly enhanced survival of mice lethally infected with C. albicans. The results reported herein delineate the biological mechanism of action of SK&F 107647, which functions via the induction of unique specific truncated forms of the chemokines KC and GROβ. To our knowledge, this represents the first example where any form of KC or GROβ were purified from marrow stromal cells. Additionally, this is the first demonstration of in vivo efficacy of a CXC chemokine in an animal infectious fungal disease model.


Experimental Mycology | 1984

Identification of a17β-estradiol binding protein inCandida albicans andCandida (Torulopsis) glabrata

Bernard L. Powell; Carrie L. Frey; David J. Drutz

Abstract The presence of a corticosterone binding system in Candida albicans has been confirmed, and a specific binding system for17β-estradiol has been identified in C. albicans and C. glabrata . The dissociation constants (approximately 6 × 10 −8 M and approximately 2 × 10 −8 M , respectively) are in the range of those encountered in mammalian systems. Competition for binding sites was exhibited only by estrogenic steroids. Unlike the situation in mammalian systems, neither diethylstilbestrol nor tamoxifen was competitive. More detailed studies with C. albicans indicated that viable, intact fungal cells also incorporated17β-estradiol in a specific manner.


The Journal of Infectious Diseases | 1996

Treatment of Experimental Gram-Negative and Gram-Positive Bacterial Sepsis with the Hematoregulatory Peptide SK&F 107647

Peter DeMarsh; Grace I. Wells; Thomas Lewandowski; Carrie L. Frey; Pradip K. Bhatnagar; Evelyn Judith R. Ostovic


The Journal of Infectious Diseases | 1988

Demonstration, by Immunoelectronmicroscopy, of a Cell Wall Antigen in Trichosporon beigelii That Cross-Reacts with Cryptococcus neoformans Capsular Polysaccharide

Gregory P. Melcher; Michael G. Rinaldi; Carrie L. Frey; David J. Drutz


Immunopharmacology | 1994

Efficacy of the hematoregulatory peptide SK&F 107647 in experimental systematic Candida albicans infections in normal and immunosuppressed mice

Peter L. DeMarsh; Scott K. Sucoloski; Carrie L. Frey; Pradip K. Bhatnagar; Yigal Koltin; Paul Actor; Stephen Robert Petteway


The American review of respiratory disease | 1989

Divergent patterns of pulmonary blastomycosis induced by conidia and yeasts in athymic and euthymic mice

Carrie L. Frey; Peter L. DeMarsh; David J. Drutz


Botany | 1995

The hematoregulatory peptide, SK&F 107647, in combination with antifungal therapy in murine Candida albicans infections

Peter L. DeMarsh; Scott K. Sucoloski; Carrie L. Frey; Louis M. Pelus; Pradip K. Bhatnagar; Yigal Koltin; Paul Actor; Stephen R. Pettaway


Archive | 1991

Method for treating fungal infection

Geoffrey Bainbridge Dreyer; Carrie L. Frey; Yigal Koltin


Archive | 2013

Anti-Infective Activities Chemokines with Potent Hematopoietic and βof Unique Truncated KC/GRO

Louis M. Pelus; Joanna Maria Balcarek; Zdenka L. Jonak; Pradip K. Bhatnagar; Patrick McDevitt; Dean E. McNulty; Andrew G. King; Kyung Johanson; Carrie L. Frey; L Peter


Archive | 1993

Inhibiteurs du facteur necrotique tumoral

Klaus Max Esser; Peter DeMarsh; Carrie L. Frey

Collaboration


Dive into the Carrie L. Frey's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge